FDA Approves Taro’s Keveyis™ (dichlorphenamide) for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Orphan Drug is First Approved Treatment for Patients Living with Rare Debilitating Disease
Keveyis is now supplied free of charge to US patients by Taro Pharmaceuticals. The process is handled by Envoy Health.
The numbers for Envoy are: 1-855-768-9727 and 1-810-553-4090.
You need a prescription from your doctor, but call Envoy first for instructions on how to apply and proceed.